HEXA rs121907980: Understanding Carrier Status and Tay-Sachs

What each genotype means

What is rs121907980?

The rs121907980 variant is a single nucleotide polymorphism (SNP) located on chromosome 15 within the HEXA gene. In genetic research, this variant is identified by its specific position in the human genome. It is classified as a pathogenic variant, meaning that changes at this location can disrupt the normal function of the gene. Because Tay-Sachs disease is an autosomal recessive condition, individuals typically need to inherit two copies of a pathogenic variant—one from each parent—to manifest the disease. When an individual carries only one copy of such a variant, they are generally considered a carrier. Carriers are typically asymptomatic, as the remaining functional copy of the gene is usually sufficient to produce enough enzyme for normal cellular processes. Understanding this variant requires looking at the specific DNA sequence changes that alter the protein-coding instructions for the HEXA enzyme.

The Role of the HEXA Gene

The HEXA gene provides instructions for making one part of an enzyme called beta-hexosaminidase A. This enzyme is located in lysosomes, which are the recycling centers of cells. Its primary function is to break down a fatty substance known as GM2 ganglioside. When the HEXA gene is mutated, the resulting enzyme may be absent, reduced in quantity, or non-functional. Without a working enzyme, GM2 ganglioside cannot be properly degraded and begins to accumulate to toxic levels within nerve cells in the brain and spinal cord. This progressive buildup leads to the neurological symptoms associated with Tay-Sachs disease and other GM2-gangliosidosis disorders. Because the enzyme is critical for maintaining the health of neurons, the severity of the condition often correlates with the amount of residual enzyme activity remaining in the body.

Research and Clinical Significance

The association between the HEXA gene and Tay-Sachs disease is well-established in medical literature and clinical genetics. Research has identified over 175 different variants in the HEXA gene that can contribute to the disease. The rs121907980 variant is specifically documented in databases like ClinVar as having a pathogenic significance. Clinical validity frameworks, such as those used by ClinGen, have confirmed that mutations in HEXA are definitively linked to Tay-Sachs disease. While the evidence for this specific variant's pathogenicity is strong, it is important to note that clinical outcomes can vary based on the specific combination of variants an individual carries. Genetic testing for HEXA variants is a standard practice in carrier screening programs, particularly for populations where these mutations are more prevalent. This testing helps individuals understand their reproductive risks and informs family planning decisions.

Population Frequency and Interpretation

The rs121907980 variant is considered rare in the general population. Tay-Sachs carrier screening has historically focused on specific ethnic groups, such as Ashkenazi Jews and French Canadians, where certain founder mutations are more common. However, pathogenic variants in the HEXA gene can occur in any population. Because this variant is rare, most individuals will not carry it. It is crucial to understand that genetic information is complex and should not be used for self-diagnosis. If you have received results indicating you are a carrier of a HEXA variant, this information is primarily relevant for understanding the risk of passing the condition to future children. You should always discuss your genetic test results with a qualified healthcare provider or a genetic counselor who can provide context based on your personal and family medical history.

Frequently asked questions

Sources & further reading

Related variants in HEXA